Shenzhen TargetRx

Shenzhen TargetRx (Chinese: 深圳市塔吉瑞生物医药股份有限公司; also known as TJR Biosciences) is a biopharmaceutical company headquartered in Shenzhen, China. According to its official website, the company focuses on the development of next-generation targeted anti-tumor drugs. Its stated mission is to overcome tumor drug resistance through precision medicine and to improve patients' lives. The company designs structurally unique molecules intended to overcome resistance to existing therapies and to address unmet clinical needs. The company describes itself as advancing a pipeline of clinical candidates aimed at transforming patient outcomes. Its website highlights a focus on "new-generation, clinically urgently needed targeted original innovative drugs" and invites collaboration in biomedical innovation and product research and development. TargetRx positions itself at the intersection of precision medicine and oncology drug discovery, with an emphasis on original innovation rather than generic or me-too products. Shenzhen TargetRx is located in the Nanshan District of Shenzhen, at Ke Xing Science Park (科兴科学园), Building A1, 3rd Floor. The company maintains a public contact telephone number (+86-0755-86934300) and email address (targetrx@tjrbiosciences.com). It also operates an official WeChat public account (塔吉瑞公众号). The company's website is available in both Chinese and English, reflecting an intention to engage with both domestic and international audiences. As a privately held biopharmaceutical company, Shenzhen TargetRx appears to be focused on drug discovery and clinical development. Its pipeline is described as consisting of clinical candidates, suggesting that it has progressed beyond preclinical stages for at least some programs. The company emphasizes a world-class team with an entrepreneurial and innovative spirit, and it actively recruits talent. It also seeks partnerships for innovative technology exploration and product research and development in the biomedical field. Specific details such as founding year, founders, ownership structure, and financial status are not provided in the available evidence. The company is not known to be publicly listed based on the evidence at hand. Its core identity is that of an oncology-focused biotechnology company dedicated to precision medicine and overcoming drug resistance.

Shenzhen TargetRx (深圳市塔吉瑞生物医药股份有限公司) is a biopharmaceutical company based in Shenzhen, China. The available evidence does not specify its founding date or early history. The company's official website describes its focus on developing next-generation targeted anti-tumor drugs. It states a mission to overcome tumor drug resistance through precision medicine and to improve patients' lives. The company designs structurally unique molecules to overcome resistance to existing therapies and to address unmet clinical needs. TargetRx describes itself as advancing a series of clinical candidates intended to change patients' lives. Its website emphasizes "new-generation, clinically urgently needed targeted original innovative drugs" and invites collaboration in biomedical innovation and product research and development. The company also highlights a world-class team with an entrepreneurial and innovative spirit and actively recruits talent. The company is located in the Nanshan District of Shenzhen, at Ke Xing Science Park (科兴科学园), Building A1, 3rd Floor. It provides a contact telephone number (+86-0755-86934300) and email address (targetrx@tjrbiosciences.com). It also operates an official WeChat public account (塔吉瑞公众号). The website is available in both Chinese and English. As of the available evidence, Shenzhen TargetRx appears to be a privately held company focused on oncology drug discovery and clinical development. No information on founders, ownership, funding, or public listing is provided. The company's history is primarily characterized by its ongoing efforts to develop innovative cancer therapies.

Developer of next-generation targeted anti-tumor drugs designed to overcome drug resistance and address unmet clinical needs through precision medicine.

1. 1塔吉瑞tjrbiosciences.com
2. 2Shenzhen TargetRxwikidata.org